Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198058 | SCV001368843 | uncertain significance | Myopathy, centronuclear, 5 | 2019-06-22 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PP3. This variant was detected in homozygous state. |
Ce |
RCV002511054 | SCV002821031 | uncertain significance | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | SPEG: PM2, PM3:Supporting, PP4 |
Gene |
RCV002511054 | SCV003933404 | uncertain significance | not provided | 2022-12-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously reported as a pathogenic or benign germline variant to our knowledge; This variant is associated with the following publications: (PMID: 28098136) |
3billion, |
RCV001198058 | SCV004013491 | uncertain significance | Myopathy, centronuclear, 5 | criteria provided, single submitter | clinical testing | The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: <0.001%). Therefore, this variant is classified as Uncertain significance according to the recommendation of ACMG/AMP guideline. |